Benefits of Dry Needling in Trigger Points on Autonomic Nervous System, Photoelectric Plethysmography, Body Composition in Patients With Fibromyalgia Syndrome.

Universidad de Almeria1 site in 1 country64 target enrollmentMarch 2016

ConditionsFibromyalgia Trigger Points

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Fibromyalgia
Sponsor: Universidad de Almeria
Enrollment: 64
Locations: 1
Primary Endpoint: Changes Scores on Visual Analoge Scale
Status: Completed
Last Updated: 8 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study evaluates the benefits of dry needling in trigger points on autonomic nervous system, photoelectric plethysmography, body composition in patients with fibromyalgia syndrome.

Detailed Description

Dru needling can be developed on active trigger points. Myofascial trigger points can be active or latent. An active myofascial trigger point pain causes giving a specific pathological picture. We will conduct a location of myofascial trigger points following the illustrations location myofascial trigger points that indicate Travell and Simons both left-sided and right.

Registry

clinicaltrials.gov

Start Date

March 2016

End Date

February 2017

Last Updated

8 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Universidad de Almeria

Responsible Party

Principal Investigator

Adelaida María Castro-Sánchez

PhD (Lecturer)

Universidad de Almeria

Eligibility Criteria

Inclusion Criteria

•Fibromyalgia syndrome diagnosis.
•Aged from 18 to 65 years.
•No regular physical activity.
•Limitation of usual activities due to pain on at least 1 day in the previous 30 days.
•Agreement to attend evening therapy sessions.

Exclusion Criteria

•Severe physical disability.
•Comorbid conditions (eg, morbid obesity, inflammatory diseases, irritable bowel syndrome, interstitial cystitis).
•Uncontrolled endocrine disorders (eg, hyperthyroidism or hypothyroidism, diabetes).
•Malignancy.
•Psychiatric.
•Illnesses (eg, schizophrenia or substance abuse).
•Medication usage other than as-needed analgesics (excluding long-term narcotics).
•History of surgery.
•History of whiplash injury.
•Presence of a score \>9 points in the Beck Depression Inventory.

Outcomes

Primary Outcomes

Changes Scores on Visual Analoge Scale

Time Frame: At baseline and 4 weeks

Intensity of pain (within McGill questionnaire)

Secondary Outcomes

Changes Scores on Percentage Evaluation Peripheral Capillary Oxygen saturation and photoelectric plethysmograph (Analysis of pulse wave and PANI)(At baseline and 4 weeks)
Change Scores on Body Composition(At baseline and 4 weeks)
Changes Scores on Systemic vascular resistance.(At baseline and 4 weeks)
Changes Scores on Heart rate variability.(At baseline and 4 weeks)
Changes Scores on Valsalva ratio. K30/15.(At baseline and 4 weeks)
Changes Scores on Assessment of autonomic nervous system(At baseline and 4 weeks)
Changes Scores on Cholinergic response indicators (%).(At baseline and 4 weeks)
Changes Scores on Systolic pressure.(At baseline and 4 weeks)
Changes Scores on Diastolic pressure.(At baseline and 4 weeks)